Pivoting your products
When initial target indications or markets are no longer feasible, it is critical to pivot your products rapidly. How do we plan for pivoting to give minimal disruption and maximum success?
Feb 1, 2022
When initial target indications or markets are no longer feasible, it is critical to pivot your products rapidly. How do we plan for pivoting to give minimal disruption and maximum success?
Home testing has become routine in the pandemic. Can this lead to more widespread home disease #diagnosis? Dive deep into this topic at #MedTechIntegrates with panellists from @CDP_innovation @UK_ABHI @RocheDiaUK 52 North Health @thrivahealth @Hologic
https://www.lifescienceintegrates.com/medtech-integrates-2022/
Market access isn't the only barrier for #MedTech: accessing clinicians can also be difficult. How can we engage clinicians more readily? Hear Kathryn Simpson explore this at MedTech Integrates with experts from @RoyalPapworth @MFTnhs @SEHTA_UK @BDandCo
https://www.lifescienceintegrates.com/medtech-integrates-2022/
When initial target indications or markets are no longer feasible, it is critical to pivot your products rapidly. How do we plan for pivoting to give minimal disruption and maximum success?